




Searching News Database: Matrix Laboratories
HSMN NewsFeed - 23 Feb 2012
Mylan Receives Tentative FDA Approval Through PEPFAR for Pediatric HIV/AIDS Therapy
Mylan Receives Tentative FDA Approval Through PEPFAR for Pediatric HIV/AIDS Therapy
HSMN NewsFeed - 15 Feb 2012
Mylan to Change Name of Specialty Subsidiary From Dey Pharma to Mylan Specialty
Mylan to Change Name of Specialty Subsidiary From Dey Pharma to Mylan Specialty
HSMN NewsFeed - 24 Jan 2011
Mylan's Matrix Receives Approval for Generic Version of Protonix(R) Delayed-release Tablets
Mylan's Matrix Receives Approval for Generic Version of Protonix(R) Delayed-release Tablets
HSMN NewsFeed - 19 Apr 2010
Mylan Announces Approval Under PEPFAR for Generic Version of Videx(R) EC HIV Treatment
Mylan Announces Approval Under PEPFAR for Generic Version of Videx(R) EC HIV Treatment
HSMN NewsFeed - 30 Mar 2009
Mylan's Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
Mylan's Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)
HSMN NewsFeed - 20 Mar 2009
Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
HSMN NewsFeed - 30 Dec 2008
Mylan's Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules
Mylan's Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules
HSMN NewsFeed - 21 Apr 2008
Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
Mylan Announces Final FDA Approval for Felodipine Extended-Release Tablets, USP
HSMN NewsFeed - 27 Feb 2008
Mylan Announces Appointment of Jagdish Dore' as CEO and Managing Director of Matrix Laboratories
Mylan Announces Appointment of Jagdish Dore' as CEO and Managing Director of Matrix Laboratories
HSMN NewsFeed - 25 Feb 2008
Mylan Announces Appointment of Eric M. Leeds as Senior Vice President and Head of Global Investor Relations
Mylan Announces Appointment of Eric M. Leeds as Senior Vice President and Head of Global Investor Relations
HSMN NewsFeed - 18 Dec 2007
Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
HSMN NewsFeed - 4 Dec 2007
Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
Mylan Announces Tentative FDA Approval Under PEPFAR for Tenofovir Disoproxil Fumarate Tablets
HSMN NewsFeed - 2 Dec 2007
FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension
FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension
HSMN NewsFeed - 30 Oct 2007
Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel
Mylan Announces Appointment of Joseph F. Haggerty as Senior Vice President and Global General Counsel
HSMN NewsFeed - 23 Oct 2007
Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
HSMN NewsFeed - 2 Oct 2007
Mylan Appoints Rajiv Malik as Executive Vice President, Head of Global Technical Operations
Mylan Appoints Rajiv Malik as Executive Vice President, Head of Global Technical Operations
HSMN NewsFeed - 2 Oct 2007
Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
Mylan Announces Appointment of Didier Barret as President, Europe, Middle East and Africa
HSMN NewsFeed - 2 Oct 2007
Mylan Announces Appointment of Harry A. Korman as President, North America
Mylan Announces Appointment of Harry A. Korman as President, North America
HSMN NewsFeed - 1 Oct 2007
Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
Mylan Announces Appointment of Brian Byala as Senior Vice President and Treasurer
HSMN NewsFeed - 1 Oct 2007
Mylan Announces Appointment of Gregory L. (Greg) Sheldon as Global Chief Information Officer
Mylan Announces Appointment of Gregory L. (Greg) Sheldon as Global Chief Information Officer
HSMN NewsFeed - 14 Sep 2007
Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
Mylan Announces Appointment of M. Fabiana Lacerca as Senior Vice President and Chief Compliance Officer
HSMN NewsFeed - 10 Aug 2007
Mylan Announces Final FDA Approval for Verapamil Hydrochloride Extended-Release Capsules (PM)
Mylan Announces Final FDA Approval for Verapamil Hydrochloride Extended-Release Capsules (PM)
HSMN NewsFeed - 31 May 2007
Mylan Announces Tentative FDA Approval for Paroxetine Hydrochloride Extended-Release Tablets
Mylan Announces Tentative FDA Approval for Paroxetine Hydrochloride Extended-Release Tablets
HSMN NewsFeed - 1 May 2007
Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol
Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol
HSMN NewsFeed - 23 Apr 2007
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
Mylan Announces Final FDA Approval and Immediate Shipment of Zolpidem Tartrate Tablets
HSMN NewsFeed - 18 Apr 2007
FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
HSMN NewsFeed - 13 Apr 2007
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
HSMN NewsFeed - 27 Mar 2007
U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs
U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs
HSMN NewsFeed - 26 Mar 2007
Mylan Announces Another First to Market With the Launch of Ciprofloxacin Extended-Release Tablets
Mylan Announces Another First to Market With the Launch of Ciprofloxacin Extended-Release Tablets
HSMN NewsFeed - 14 Mar 2007
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
Mylan Announces Tentative FDA Approval for Divalproex Sodium Extended-Release Tablets
HSMN NewsFeed - 26 Feb 2007
Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
Mylan Announces Tentative FDA Approval for Ondansetron Orally Disintegrating Tablets, USP
HSMN NewsFeed - 16 Feb 2007
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
Mylan Announces Final FDA Approval for Propranolol Hydrochloride Extended-Release Capsules, USP
HSMN NewsFeed - 8 Feb 2007
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
Mylan Announces Final FDA Approval for Sotalol Hydrochloride Tablets, USP (AF)
HSMN NewsFeed - 31 Jan 2007
Mylan Announces Final FDA Approval for Its 12 mcg/hr Fentanyl Transdermal System
Mylan Announces Final FDA Approval for Its 12 mcg/hr Fentanyl Transdermal System
HSMN NewsFeed - 31 Jan 2007
Mylan Announces Tentative Approval for Valacyclovir Hydrochloride Tablets
Mylan Announces Tentative Approval for Valacyclovir Hydrochloride Tablets
HSMN NewsFeed - 30 Jan 2007
Mylan Announces Final FDA Approval for Albuterol Sulfate Extended-Release Tablets
Mylan Announces Final FDA Approval for Albuterol Sulfate Extended-Release Tablets
HSMN NewsFeed - 28 Aug 2006
Mylan Laboratories to Acquire Up to 71.5% Controlling Interest in Matrix Laboratories
Mylan Laboratories to Acquire Up to 71.5% Controlling Interest in Matrix Laboratories